Is Synlogic Inc (SYBX) overvalued? · P/E 5.5, $14.2M cap
Synlogic Inc (SYBX) is a biotechnology company listed on US.
This page asks whether Synlogic Inc (SYBX) looks expensive on cached numbers — not a short thesis.
Latest reported SYBX revenue for 2026-06-30 was $0. Net income was -$543.0K. SYBX currently screens at market cap $14.2M and trailing P/E 5.5.
SYBX currently screens at market cap $14.2M and trailing P/E 5.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SYBX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SYBX stock page for the full model, not this heading.
Not investment advice.